CA2372700A1 - Examen diagnostique pour la thrombose ou la thromboembolie - Google Patents

Examen diagnostique pour la thrombose ou la thromboembolie Download PDF

Info

Publication number
CA2372700A1
CA2372700A1 CA002372700A CA2372700A CA2372700A1 CA 2372700 A1 CA2372700 A1 CA 2372700A1 CA 002372700 A CA002372700 A CA 002372700A CA 2372700 A CA2372700 A CA 2372700A CA 2372700 A1 CA2372700 A1 CA 2372700A1
Authority
CA
Canada
Prior art keywords
fpb
seq
antibody
peptide
thrombotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002372700A
Other languages
English (en)
Inventor
Timothy A. Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2372700A1 publication Critical patent/CA2372700A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Dans cette invention, on détecte ou on surveille la thrombose ou la thromboembolie en déterminant la présence ou le taux de B dans un échantillon physiologique.
CA002372700A 1999-06-30 2000-06-30 Examen diagnostique pour la thrombose ou la thromboembolie Abandoned CA2372700A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14173499P 1999-06-30 1999-06-30
US60/141,734 1999-06-30
PCT/US2000/017977 WO2001001150A2 (fr) 1999-06-30 2000-06-30 Examen diagnostique pour la thrombose ou la thromboembolie

Publications (1)

Publication Number Publication Date
CA2372700A1 true CA2372700A1 (fr) 2001-01-04

Family

ID=22496986

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002372700A Abandoned CA2372700A1 (fr) 1999-06-30 2000-06-30 Examen diagnostique pour la thrombose ou la thromboembolie

Country Status (5)

Country Link
EP (1) EP1192183A2 (fr)
JP (1) JP2003503425A (fr)
AU (1) AU781249B2 (fr)
CA (1) CA2372700A1 (fr)
WO (1) WO2001001150A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE349703T1 (de) * 2002-08-09 2007-01-15 Dade Behring Marburg Gmbh Kombination von crp und d-dimer zur diagnose von tiefer venenthrombose
US20160047829A1 (en) * 2012-10-18 2016-02-18 Ruprecht-Karls-Universität Heidelberg Means and Methods for Determining a Clearance Normalized Amount of a Metabolite Disease Biomarker in a Sample
CN114550855A (zh) * 2020-11-25 2022-05-27 上海森亿医疗科技有限公司 基于人工智能的静脉血栓栓塞症预测方法、装置、终端及介质

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683015B2 (en) * 1992-03-13 1997-10-30 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5876947A (en) * 1997-07-25 1999-03-02 The New York Blood Center, Inc. Monospecific antibody reactive with Fibrinogen and fibrinopeptide B

Also Published As

Publication number Publication date
AU781249B2 (en) 2005-05-12
EP1192183A2 (fr) 2002-04-03
JP2003503425A (ja) 2003-01-28
WO2001001150A3 (fr) 2002-02-07
WO2001001150A9 (fr) 2002-07-25
AU6059300A (en) 2001-01-31
WO2001001150A2 (fr) 2001-01-04

Similar Documents

Publication Publication Date Title
US6673561B1 (en) Diagnostic test for thrombotic or thromboembolic disease
Declerck et al. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis
Bauer et al. Factor IX is activated in vivo by the tissue factor mechanism
US5206140A (en) Assay for soluble crosslinked fibrin polymers
Amiral et al. Application of enzyme immunoassays to coagulation testing.
Amiral et al. Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A
EP0151239A2 (fr) Anticorps monoclonaux spécifiques de fragments dérivés in vivo de fibrinogène
US8940489B2 (en) Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
JP2918688B2 (ja) プロトロンビン活性化ペプチド及びその分解産物に関するイムノアッセイ及びそれらに対するモノクローナル抗体
Hamano et al. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma
US6043087A (en) Monospecific antibody reactive with matrix metalloproteinase cleavage products of fibrin(ogen)
EP1007570B1 (fr) Anticorps monospecifique reagissant avec le fibrinogene et le fibrinopeptide b
EP0871884A1 (fr) Anticorps monospecifiques diriges contre une sous-unite de fibrinogene
US4851334A (en) Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fibrin I or human fibrin II
AU781249B2 (en) Diagnostic test for thrombotic or thromboembolic disease
AU2005203615A1 (en) Diagnostic test for thrombotic or thromboembolic disease
JP3370717B2 (ja) キャリブレーター及びイムノアッセイにおけるその使用
Sobel et al. The development of assays for the detection of fibrin (ogen) olysis based on COOH-terminal A alpha chain epitopes
US5837540A (en) Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen
Doh et al. Novel monoclonal antibody that recognizes new neoantigenic determinant of D-dimer
WO1993000364A1 (fr) METHODE DE DETECTION DE FIBRINOLYSE ET DE FIBRINOGENOLYSE BASEE SUR DES MARQUEURS DE CHAINE Aα TERMINALE COOH-
Soria et al. Markers of fibrinogen derivatives used in clinical investigation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued